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Background: Adult ADHD has been assumed to be a continuation of childhood-onset ADHD. However, recent
studies have identified individuals with ADHD in adulthood who have not had ADHD in childhood. Whether or not
these individuals have a ‘typical’ neurodevelopmental profile is not clear. Methods: We tested two explanations for
the emergence of apparent late-onset ADHD symptomatology using the ALSPAC epidemiological cohort, by grouping
individuals according to their scores on the Strengths and Difficulties Questionnaire (SDQ) hyperactivity subscale at
ages 12 and 17 years. First, we tested whether some of those with apparent late-onset ADHD symptoms had been
potentially misclassified on the basis of earlier SDQ hyperactivity scores (ages 7, 8 and 9 years) or of subthreshold
symptoms at age 12 years. Second, we investigated the possibility that those with ‘genuine’ late-onset ADHD
symptoms had a delayed manifestation of the same liability that underlies childhood-onset symptoms, by
investigating whether they had a similar profile of neurodevelopmental impairments (in the domains of autistic
symptomatology, language, reading, spelling, executive functioning and IQ) as those with typical childhood-onset
ADHD. Results: N = 56/75 (75%) of those with apparent late-onset ADHD had had high ADHD scores at least one
point in childhood, suggesting that they may have been misclassified on the basis of their score at age 12 years. The
remaining 19 individuals (25%) with genuine late-onset ADHD symptoms did not show a profile of neurodevelop-
mental impairment typically seen in ADHD, instead showing similar levels of autistic symptoms, language skills,
executive functioning ability and IQ to those without ADHD symptoms. The only exceptions were that this group
showed reading and spelling problems at age 9 years. Conclusions: Our work suggests that this small number of
individuals with genuine late-onset symptoms may not be most appropriately considered as having a typical
neurodevelopmental disorder. Keywords: Late-onset ADHD; neurodevelopment; Avon Longitudinal Study of Parents
and Children; Strengths and Difficulties Questionnaire.
Introduction
Attention deficit hyperactivity disorder (ADHD) is
conceptualised by the DSM-5 (American Psychiatric
Association, 2013) as a childhood-onset neurodevel-
opmental disorder. Symptoms tend to attenuate with
age, although around 60% of individuals have
symptom persistence into adulthood and 40% show
both symptom persistence and impairment (Sibley,
Swanson et al., 2017). Adult ADHD has been
assumed to be a continuation of childhood ADHD.
Its diagnostic criteria require childhood onset and
allow for the developmental change in symptoms
over time, with fewer symptoms in each category
needing to be endorsed for diagnostic criteria to be
met (American Psychiatric Association, 2013).
However, recent findings have challenged the
assumption of this trajectory. First, a prospective
population study from New Zealand (Moffitt et al.,
2015) found that 87% of those with adult ADHD,
ascertained by structured interview at age 38 years,
had no history of childhood ADHD on the basis of
assessments made during childhood. In this study,
adult ADHD status was not associated with the male
preponderance, neuropsychological deficits or child
ADHD genetic liability (as indexed by ADHD poly-
genic risk scores) typical of childhood onset ADHD,
leading the authors to conclude that adult ADHD
may not be a continuation of the childhood neurode-
velopmental disorder and may have a different
aetiology. Second, a Brazilian birth cohort study
(Caye et al., 2016) found 85% of their young adult
ADHD group, as ascertained at age 18–19 years
without requiring the ‘age at onset’ criterion, had not
met criteria in childhood (age 11 years). This young
adult group had a female preponderance and a range
of adverse outcomes including criminality, suicide
attempts and comorbidities. Third, a UK twin study
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(Agnew-Blais et al., 2016) found that 67% of their
young adult ADHD group, as defined at age 18 years
again without requiring the ‘age of onset’ criterion,
had not met criteria when assessed for ADHD in
childhood (at ages 5, 7, 10 and 12 years). Those with
late-onset disorder were more likely to be female,
had fewer behaviour problems and higher IQ in
childhood than those with persistent ADHD, though
were similar in ADHD symptom levels, impairment
and mental health comorbidities at age 18 years.
However, the findings of these studies have been
viewed with caution by some, especially because
adult diagnoses, unlike child ADHD, were based
primarily on self-report (Faraone & Biederman,
2016). Thus, it is likely too early to conclude that
the adult-onset ADHD groups are truly distinct from
the childhood disorder (Faraone & Biederman,
2016).
Indeed, a very recent analysis seeking to address
some of the methodological difficulties associated
with the population studies investigating late-
onset ADHD found that after careful scrutiny,
95% of the control group in the Multimodal
Treatment of ADHD (MTA) study who initially
screened positive on checklists for late-onset
ADHD did not actually meet criteria for a diagno-
sis, with the occurrence of ADHD symptoms only
in the context of heavy substance misuse being
the most common reason for this (Sibley, Rohde
et al., 2017) and only 2% of the group met criteria
for a diagnosis of late-onset ADHD after excluding
cases with subthreshold ADHD symptoms in
childhood. Nevertheless, the findings from the
three population studies showing apparent ADHD
in adulthood without a preceding childhood his-
tory cannot be dismissed – the correlates of this
presentation need further exploration.
As part of a recent genetic study from our group
(Riglin et al., 2016) using a UK birth cohort (Avon
Longitudinal Study of Parents and Children,
ALSPAC), we identified a group of 122 children
(2.5% of the sample) who scored in the abnormal
range on the Strengths and Difficulties Question-
naire (SDQ, Goodman, 1997) hyperactivity subscale
at age 17 years without having had borderline or
abnormal symptom scores at age 7 years [the age of
onset cut-point for ICD-10 (World Health Organisa-
tion, 1992)]. The aim of the current paper was to
investigate the characteristics of those with apparent
late-onset ADHD as defined by having high or very
high scores on the SDQ hyperactivity subscale at age
17 years, but not prior to or at age 12 years (i.e. the
age-of-onset criterion for DSM-5 diagnosis). The data
collected at multiple time points in ALSPAC mitigate
some, but not all of the methodological difficulties
surrounding the cohorts used in the previous anal-
yses. First, the same measures were used through-
out childhood and late adolescence, meaning that
the emergence of later symptomatology is not purely
ascribable to the use of different measures. Second,
parent report was available for all time points, as
self-reported ADHD symptoms can be unreliable
(Danckaerts, Heptinstall, Chadwick, & Taylor,
1999) and different informants are known to show
at best only modest agreement. Also, as was the case
in the other cohorts, all measures were obtained
prospectively, meaning that recall bias, which can be
associated with longitudinal studies of ADHD (Sibley
et al., 2012), is not an issue.
We tested two explanations for the emergence of
late-onset ADHD symptomatology:
1. Those with apparent late-onset ADHD symptoms
include individuals who had shown slightly raised
or high ADHD symptomatology at least one point
in childhood, that is, they have been potentially
misclassified on the basis of their score at age
12 years.
2. Late-onset ADHD symptoms are a delayed man-
ifestation of the same liability that underlies
childhood-onset symptoms – such that those with
late-onset symptoms have a similar profile of
neurodevelopmental impairments as those with
typical childhood-onset ADHD (Thapar, Cooper,
& Rutter, 2016).
Methods
Sample
ALSPAC is a well-established ongoing prospective longitudinal
birth cohort study which started in September 1990. The
enrolled core sample consisted of 14,541 mothers living in
Avon, England, who had expected delivery dates between April
1, 1991, and December 31, 1992. Of these pregnancies,
13,988 children were alive at 1 year. When the oldest children
were aged around 7 years, the sample was increased by
n = 713 by recruiting eligible families who had not originally
joined the study. The resulting total sample size of children
who were alive at 1 year was 14,701. Ethical approval for the
study was obtained from the ALSPAC Ethics and Law Com-
mittee and the Local Research Ethics Committees. All partic-
ipants gave written informed consent. Full details of the study,
measures and sample can be accessed elsewhere (Boyd et al.,
2013; Fraser et al., 2013). Please note that the study website
contains details of all the data that is available through a fully
searchable data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary). For families with
multiple births, we included the oldest sibling. We included
individuals in our analyses when primary data on ADHD
symptoms were available for at ages 12 and 17 years,
(n = 4,953).
ADHD symptom groups
ADHD symptoms were assessed at five time points during
childhood and adolescence (roughly ages 7, 8, 9, 12 and
17 years) using the parent-rated 5-item SDQ subscale which
includes hyperactive and inattentive symptoms (score range 0–
10) (Goodman, 1997). In our previous work (Riglin et al.,
2016), SDQ hyperactivity subscale scores were classified as
normal (scores of 0–5), borderline (6) or abnormal (7–10) as per
the SDQ’s original 3-band categorisation. For the current
analyses, SDQ hyperactivity scores were classified as close to
average (0–5), slightly raised (6–7), high (8) and very high (9–
10) using the latest 4-band classification validated in a large
UK community sample (Green, McGinnity, Meltzer, Ford, &
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Goodman, 2005). We defined ADHD symptom groups based on
parent-rated SDQ hyperactivity subscale scores during child-
hood (up to and including age 12 years, as per DSM-5 age-of-
onset criterion for ADHD diagnosis) and adolescence (age
17 years) as follows. Individuals were initially categorised
based on whether they scored low (close to average or slightly
raised score, i.e. 0–7) or high (i.e. 8–10) at ages 12 and 17 years
into one of four ADHD groups: low symptoms, childhood-
limited, childhood-onset persistent and apparent late-onset.
The apparent late-onset group was then divided into: (a)
potential misclassification – individuals with elevated (slightly
raised, high or very high, i.e. 6–10) scores at ages 7, 8 or
9 years, or with a slightly raised score (i.e. 6–7) at age 12 years
i.e. individuals with subthreshold/high symptoms at an earlier
point in childhood and/or subthreshold symptoms at age
12 years, and (b) genuine late-onset – those with close to
average scores at every time point in childhood (ages 7–
12 years). The categorisation of ADHD symptom groups is
shown in Table 1.
Family income, emotional, behavioural and social
problems, and substance misuse
The following variables were examined for descriptive pur-
poses. Family income was classified as below average or above
average using a (within-sample) median split. Scores on the
SDQ emotional problems, conduct problems, prosocial beha-
viour and peer problems subscales were used to describe
difficulties in these domains at ages 12 and 17 years. All SDQ
subscales are scored out of 10; higher scores represent greater
impairment except for prosocial behaviour, where lower scores
represent lower levels of prosocial traits which reflects more
impairment (Goodman, 1997). The self-report 10-item Alcohol
Use Disorders Identification Test (Babor, Higgins-Biddle, &
Saunders, 2001), which is a brief screening tool to identify
individuals with alcohol-related problems, was completed by
the young person at approximately age 17 years via postal
questionnaire. The AUDIT scale has been studied extensively
and has high validity and reliability in the detection of risky
drinking, alcohol misuse and alcohol dependence (Allen,
Litten, Fertig, & Babor, 1997). Cannabis use was assessed in
the same postal questionnaire with the question ‘Have you ever
tried cannabis (also called marijuana, hash, dope, pot, skunk,
puff, grass, draw, ganja, spliff, joints, smoke, weed)’.
Neurodevelopmental characteristics
Autistic traits were measured at age 8 years using the Social
Communication Disorders Checklist (Skuse, Mandy, &
Scourfield, 2005), a parent-rated 12-item scale assessing
abnormalities in the domains of reciprocal social interaction
and communication, with each item being scored from 0–2
and higher scores representing higher levels of autistic traits.
Pragmatic language difficulties, intelligibility/fluency and
syntax were assessed at age 9 years using the Children’s
Communication Checklist 2 (Norbury, Nash, Baird, &
Bishop, 2004), a parent-rated questionnaire assessing vari-
ous aspects of communication, with lower scores represent-
ing greater impairment. Reading and spelling were assessed
at age 9 years by asking the child to read 10 (real) words
selected from previous research (Nunes, Bryant, & Olsson,
2003) and to spell 15 words. IQ was assessed at age 8 years
using the Wechsler Intelligence Scale for Children [WISC-IV,
(Wechsler, 2003)], which assesses an age-scaled full-scale IQ
comprising 10 subtests contributing to four cognitive
domains: verbal comprehension index (VCI), perceptual rea-
soning index (PRI), working memory index (WMI), and
processing speed index (PSI). Executive functioning was
measured using the digit span score from the WISC-IV, in
which lower scores reflect poorer executive functioning. IQ
was measured at age 16 years using the two-subtest form of
the Wechsler Abbreviated Scale of Intelligence (WASI, Wech-
sler, 1999).
Analysis strategy
First, we identified the number of individuals with apparent
late-onset symptoms. To test hypothesis 1, we examined how
many of these were subsequently categorised as cases of
potential misclassification.
For descriptive purposes, groups were compared on family
income, emotional, behavioural and social problems, and
substance misuse problems.
To test our second hypothesis, we compared the genuine
late-onset group to (a) the low symptoms group (i.e. for those
without childhood symptoms, comparing those with to those
without adolescent symptoms) and (b) the childhood-onset
persistent group (i.e. for those with adolescent symptoms,
comparing those without to those with childhood symptoms)
on a range of neurodevelopmental characteristics, using logis-
tic/linear regression as appropriate. The groups were com-
pared on established indicators of neurodevelopmental risk
and symptomatology known to be associated with ADHD
(Thapar, Cooper, Eyre, & Langley, 2013; Thapar & Rutter,
2015; Thapar et al., 2016) – namely autistic traits, pragmatic
language, intelligibility/fluency and syntax, reading and
spelling difficulties, executive functioning and IQ. These anal-
yses were to illustrate differences in the level of neurodevelop-
mental symptomatology between the groups, not to examine a
direction of effect in relation to ADHD symptom group mem-
bership. Scores on the SDQ, SCDC, CCC-2 were prorated if
<30% of data were missing.
Our primary analyses were conducted on an imputed
dataset based on cases with complete data on ADHD symp-
toms at ages 12 and 17 years, (n = 4,953). Of these individ-
uals, the number of respondents with complete data on other
variables in the analysis ranged from 3,383 (for adolescent IQ)
Table 1 Categorisation of ADHD groups according to SDQ hyperactivity subscale scores at different time points
Low symptoms
Childhood-
limited
Childhood-onset
persistent Apparent late-onset
SDQ score
age 12 years
Close to average or
slightly raised (0–7)
High or very
high (8–10)
High or very
high (8–10)
Close to average
or slightly
raised (0–7)
Misclassification
Slightly raised (6–7), high (8)
or very high score (9–10) at
ages 7, 8, or 9 years, or
slightly raised score (6–7)
at age 12 years
Genuine late-onset
Close to average score (0–5)
at ages 7, 8, 9 and 12 years
SDQ score
age 17 years
Close to average or
slightly raised (0–7)
Close to average
or slightly
raised (0–7)
High or very
high (8–10)
High or very
high (8–10)
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to 4,953 (for child sex). Missing data were imputed using
multivariate imputation by chained equations (Van Buuren &
Oudshoorn, 2000), which assumes that data are missing-at-
random (MAR; i.e. given the observed data included in the
imputation model, the missingness mechanism does not
depend on the unobserved data (White, Royston, & Wood,
2011). Missing data were found to be dependent on several
observed variables available for the full cohort at birth or the
early postnatal period (such as family income, maternal
education, financial hardship, and parental mental health
and substance use); therefore, these were included in the
imputation model to make the assumption of MAR as plau-
sible as possible. In addition, the imputation model included
all variables included in the analysis models, and a number of
auxiliary variables that were strongly associated with the
measures to be imputed (such as multiple measures of child
substance use, cognition, communication skills and mental
health at other ages). Using binary and multinomial logistic
and linear regression models as appropriate, 100 imputed
datasets were derived, each with 10 cycles of regression
switching. Predictive mean matching was used when contin-
uous variables were not normally distributed. All analyses
were then run on imputed datasets by combining estimates
using Rubin’s rules (White et al., 2011) using STATA version
15. Sensitivity analyses conducted on the complete data
(without imputation) are presented in the supporting infor-
mation in the online version of this article.
Results
Of 4,953 individuals with SDQ hyperactivity data at
ages 12 and 17 years, n = 4,692 (94.7%) were cate-
gorised in the low symptoms group, n = 119 (2.4%)
were in the childhood-limited group, n = 55 (1.1%)
were in the childhood-onset persistent group and
n = 87 (1.7%) were in the apparent late-onset group.
Hypothesis 1
Of the 87 individuals with apparent late-onset symp-
toms, n = 12 (13.8%) had insufficient data prior to
age 11/12 years to establish whether they belonged
to the misclassification or genuine late-onset group
(n = 12). Of the n = 75 with sufficient data, n = 56
(74.7%) were categorised as potential misclassifica-
tion (based on the presence of slightly raised/high
symptoms on at least one childhood time point), with
n = 19 (25.3%) categorised as genuine late-onset. A
flowchart demonstrating the numbers in the groups
is shown in Figure 1.
A total of 44.1% of the low symptoms group, 63.3%
of the persistent group and 51.1% of the genuine
late-onset group were classified as below the median
family income [genuine late-onset vs. low symptoms
OR = 1.32 (95% CI: 0.44, 3.92), p = .620; genuine
late-onset vs. childhood-onset persistent OR = 0.60
(95% CI: 0.18, 2.09), p = .425].
Figure 2 shows comparisons of each of the ADHD
symptom groups on the SDQ subscales. As shown
in Table 2, the genuine late-onset group had lower
comorbid symptom levels at age 12 years than the
childhood-onset persistent group. However, at age
17 they had more comorbid symptoms than the low
symptoms group but did not differ from the child-
hood-onset persistent group for emotional prob-
lems, peer problems or prosocial behaviour.
There was weak evidence that the mean score for
alcohol use was higher for the genuine late-onset
compared to the low symptoms group [mean = 10.04
vs. 6.27: mean difference = 3.76 (95% CI: 0.07,
7.60) p = .054]; however, there was little evidence
that it differed from the childhood-onset persistent
group [mean = 7.23: mean difference = 2.81 (95%
CI: 1.43, 7.05) p = .193].
Finally, 28.1% of the low symptoms group, 32.9%
of the persistent group and 52.8% of the genuine
late-onset group reported cannabis use by age
17 years [genuine late-onset vs. low symptoms
OR = 2.87 (95% CI: 0.93, 8.91), p = .067; genuine
late-onset vs. childhood-onset persistent OR = 2.29
(95% CI: 0.60, 8.83), p = .225].
Available data
n = 4953
Low symptoms
n = 4692 (94.7%)
Childhood-limited
n = 119 (2.4%)
Apparent late-onset 
n = 87 (1.8%)
Childhood-onset persistent
n = 55 (1.1%)
Genuine late-onset
n = 19 (25.3%)
Insufficient data
n = 12
Misclassification
n = 56 (74.7%)
Figure 1 Categorising individuals based on ADHD symptoms
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Hypothesis 2
As shown in Table 3, the genuine late-onset group
showed similar scores to the low symptoms group on
neurodevelopmental features which are associated
with ADHD. The exception was that the genuine late-
onset group showed poorer reading and spelling at
age 9 years compared to the low symptoms group,
with scores that were comparable to those of the
childhood-onset persistent group.
Discussion
In this UK longitudinal population-based cohort,
using updated SDQ cut-points and excluding those
with high scores at one time point during childhood,
we find lower rates of genuine late-onset ADHD (0.4%)
than other population-based studies (Moffitt et al.,
2015, 2.7%;Agnew-Blais et al., 2016, 5%;Caye et al.,
2016,7.9%). Indeed, inour sample, 75%(56of75with
full data) of those with apparent late-onset ADHD
symptomsweredue topotentialmisclassificationonce
we had taken into account subthreshold or elevated
SDQADHDscores at least one point in childhood. This
is in keeping with research suggesting that reported
ADHD symptom levels and ADHD subgroup member-
ship (i.e. inattentive, hyperactive-impulsive) can fluc-
tuate over time (Willcutt et al., 2012). Moffitt et al.
(2015) found that their 3% prevalence of adult ADHD
at age 38 years was 90% comprised of those without a
history of childhood ADHD; Caye et al. (2016) found
that 84.6% of their 18/19 year olds with ADHD did
not have a history of childhood ADHD, and Agnew-
Blais et al. (2016) found that 67.5% of their 18 year
olds with ADHD had not met criteria for ADHD at any
assessment in childhood. Our higher rates of individ-
uals with apparent late-onset symptoms who we then
considered to actually have a childhood history of
significant ADHD symptoms (i.e. those who we are
considering as misclassified) may be explained by the
availability of multiple assessment points in child-
hood. Nevertheless, in keeping with other cohort
studies, we do identify a remaining group of what
may be genuinely late-onset ADHD.
Thus, our first hypothesis is only partially sup-
ported – a majority of late-onset ADHD could be
explained by misclassification, but this does not
account for the entire group.Wecannot infer anything
clinically relevant about the nature of the misclassi-
fication group as it is a heterogeneous group which
includes, for example, those who had ‘episodically’
raised ADHD symptoms at disparate points in child-
hood and those who had subthreshold symptoms at
age 12 years. However, we believe that the larger
number of individuals in the misclassification group,
compared to the much smaller stringently defined
genuine late-onset group, is a notable finding.
The richness of the ALSPAC dataset allows the first
detailed investigation of neurodevelopmental and
neurocognitive factors in relation to late-onset
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Figure 2 Emotional, behavioural and social problems as assessed by mean SDQ subscale scores, by ADHD symptom group. A) at age 12
years, B) at age 17 years. SDQ, Strengths and Difficulties Questionnaire. Error bars = 95% confidence intervals
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ADHD. Our second hypothesis was that late-onset
ADHD symptoms are a delayed manifestation of the
same liability that underlies childhood-onset ADHD
symptoms. We hypothesised that if this was the
case, the genuine late-onset group would share
similarities with typical childhood-onset ADHD on
measures that characterise the childhood neurode-
velopmental disorders (that include autism spec-
trum disorder, communication disorders,
intellectual disability, motor disorders and specific
learning disorders (American Psychiatric Associa-
tion, 2013, Thapar et al., 2016). ADHD and other
neurodevelopmental disorders typically show strong
overlap with each other and are characterised by
neurocognitive deficits such as impaired executive
function (Thapar & Rutter, 2015; Thapar et al.,
2016). Our results showed that the remaining gen-
uine late-onset group did not show a neurodevelop-
mental profile characterised by features or
impairment that are typical of childhood-onset
ADHD, and their childhood neurodevelopmental
profile was more similar to the low symptoms group
than to the childhood-onset persistent group in this
regard. Intriguingly, the one exception was that the
genuine late-onset group showed lower scores on
reading and spelling measures at 9 years. This was
not accompanied by language problems. We specu-
late that children with reading/spelling difficulties at
age 9 years do not show mental health problems at
this age but as they move through the educational
system, they encounter higher academic demands
and start to develop multiple mental health problems
(including ADHD-like symptoms), substance use
and peer difficulties through adolescence.
In line with our results, the adult ADHD group of
Moffitt et al. (2015) did not show a deficit in IQ (with
a mean IQ of 96.94) and the young adult group of
Agnew-Blais et al. (2016) had a mean IQ of 96.12
which was significantly higher than that of their
persistent group (89.78). Interestingly, the percent-
age of our genuine late-onset group with a household
income below the (within-group) median was 51%,
suggesting that this group does not show socioeco-
nomic disadvantage, a factor which is associated
with childhood ADHD (Russell, Ford, & Russell,
2015). However, this group did still show a male
excess, with 63% of the group being male, though
this excess was not as pronounced as that in the
‘childhood-onset’ group (80%).
Some have questioned whether adolescent-onset
ADHD symptomatology at age 17 years represents
the emergenceofamooddisorderorconductproblems,
or a substance misuse disorder (Caye, Sibley, Swan-
son, & Rohde, 2017; Sibley, Rohde et al., 2017). The
difficulty with investigating these factors is that con-
current and sequential comorbidity including sub-
stance misuse typifies childhood-onset ADHD
(Barkley, Fischer, Smallish, & Fletcher, 2004; Chang,
Lichtenstein,&Larsson,2012) so in our viewcannotbe
used to distinguish late-onset ADHD from childhood-
onset ADHD. However, in the interests of characteris-
ing the group we described symptoms of comorbid
mental health problems. Intriguingly, within the gen-
uine late-onset group, difficulties on each of the SDQ
subscales increasedbetween the age of 12 years (when
they did not appear to have emotional, behavioural or
social problems) and 17 years, when they showed
scores more comparable with the childhood-onset
persistent group. This is in contrast to the relatively
stable SDQ scores over time in both the low symptoms
and childhood-onset persistent groups. Levels of alco-
hol use and rates of cannabis use were higher in the
genuine late-onset group than in both the low symp-
toms and childhood-onset persistent groups, but the
observed associations do not appear strong enough to
explain the presence of late-onset ADHD (e.g. nearly
half the genuine late-onset group did not report having
everusedcannabis).Wecannotdetermine thedirection
of the association between late-onset symptoms of
ADHDand symptomsof othermental health problems,
or what might explain this change, beyond a possible
influence of substance use. Having said this, we found
that the levels of difficulties in the SDQ domains were
not as high as in the childhood-onset persistent group.
Thus, in this population-based cohort, we conclude
that comorbid mental health and substance misuse
problems are unlikely to fully account for the emer-
gence of late-onset ADHD symptomatology.
Table 2 Comparisons of the ADHD symptom groups on emotional, behavioural and social problems as assessed by SDQ subscale
scores
Genuine late-onset vs. low symptoms Genuine late-onset vs. childhood-onset persistent
Mean difference (95% CI) p Mean difference (95% CI) p
Childhood: age 12
Emotional problems 0.21 (0.54, 0.96) .585 1.00 (1.87, 0.13) .024
Conduct problems 0.50 (0.08, 1.08) .091 2.06 (2.73, 1.39) <.001
Prosocial behaviour 0.22 (0.95, 0.51) .559 1.37 (0.53, 2.22) .001
Peer problems 0.14 (0.54, 0.82) .691 1.08 (1.86, 0.29) .008
Adolescence: age 17
Emotional problems 1.05 (0.20, 1.91) .016 0.60 (1.59, 0.38) .227
Conduct problems 1.52 (0.92, 2.11) <.001 0.92 (1.61, 0.23) .009
Prosocial behaviour 1.01 (1.85, 0.17) .019 0.74 (0.24, 1.72) .141
Peer problems 0.68 (0.02, 1.35) .044 0.56 (1.34, 0.22) .160
NB. Mean scores for the childhood-onset persistent group were higher than for the low symptoms group on all variables at p < .001.
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
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Previous studies have found conflicting results in
this regard, with Moffitt et al. (2015) not finding a link
between childhood or adult ADHD status andmood or
anxietyproblems,Agnew-Blais et al. (2016)notfinding
elevated rates of depression and anxiety in their late-
onset ADHD group compared to the persistent group,
but Caye et al. (2016) finding elevated rates of mood
disorders and anxiety in their young adult ADHD
group.Moffittet al. (2015) foundthat theiradultADHD
group had persistently elevated rates of substance
dependence, as did the late-onset and persistent
ADHD groups of Agnew-Blais et al. (2016). On the
contrary, elevated rates of substance dependencewere
not found in the youngadultADHDgroupofCaye et al.
(2016). Our investigation was conducted in a younger
age group thansomeof theprevious studies andbefore
the peak age of onset formooddisorders (Kessler et al.,
2007) (but not conduct disorder) so the age difference
might be one contributory factor.
Strengths and limitations
As highlighted at the outset of this paper, notable
strengths are the use of the same ADHD assessment
measures throughout childhood and adolescence, the
availability of parent report at all time points, and the
prospective nature of all measures, as well as the
detailed neurodevelopmental and cognitive phenotype
data available in ALSPAC. We have also used multiple
imputation to avoid the biases associatedwithmissing
data. It is also worth mentioning that of the three
previous epidemiological studies investigatingwhether
adult ADHD is preceded by childhood ADHD, the adult
ADHD groups of Caye et al. (2016) and Moffitt et al.
(2015) do not specifically distinguish those without a
childhood history when examining phenotypic associ-
ations with group membership, with only Agnew-Blais
et al. (2016) identifying a pure late-onset group.
Limitations of our study include the small size of the
genuine late-onset group, which limits statistical
power to detect associations with the variables under
study. Second, as is the case for any longitudinal
study, therewasselective attritionover time;however,
potential bias arising from missing data was dealt
with using multiple imputation, utilising a large
amount of additional information to make the
assumption of missing-at-random as plausible as
possible. Findings from analyses using imputed data
and from complete data were very similar. Neverthe-
less, selective attrition of those likely to have the
highest ADHD symptomatology is likely (Hay, McSte-
phen, Levy, & Pearsall-Jones, 2002) and would have
affected our analytic sample (i.e. those with ADHD
data). Indeed, the childhood neurodevelopmental
characteristics that we assessedwere associatedwith
(not) being in our analytical sample (see Table S3),
which may have affected our rates of late-onset
symptoms and led to underestimated rates of accom-
panying problems. Third, our use of a screening
instrument for defining the groups will have resultedT
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in different exclusions to those using diagnostic
instruments, which has been raised as a limitation
of this type of research (Caye et al., 2017). However,
given that ADHD symptoms act as a continuously
distributed dimension in terms of associations with
risk factors and outcomes (Thapar & Cooper, 2016)
and our ADHD measure at age 17 years remained
based on the same informant at all timepoints (parent
report) as opposed to switching from parent to self-
report our investigationhasmany strengths aswell as
limitations. Nevertheless, assessment issues aside,
we do still identify a group of those with late-onset
ADHD in keeping with a previous report using a less
stringent cut-point in this same data set (Riglin et al.,
2016) as well as other studies (Agnew-Blais et al.,
2016; Caye et al., 2016; Moffitt et al., 2015; Sibley,
Rohde et al., 2017).
Summary and clinical relevance
In summary, 75% of those with apparent late-onset
symptoms were due to potential misclassification in
childhood. The remaining genuine late-onset group
did not show a characteristic neurodevelopmental
profile with the only exception being lower scores on
spelling and reading measures in middle childhood.
However, they showed elevated scores on measures
of behavioural, emotional, social and peer problems
by late adolescence, and a trend towards higher
levels of alcohol and cannabis use.
The existence of this group is of clinical signifi-
cance as it implies that there may be a small number
of individuals who will present with ADHD symp-
toms in late adolescence without either a childhood
history of inattention or hyperactivity (currently
required for diagnosis) or the profile of neurodevel-
opmental and social adversity often associated with
ADHD. These individuals need further characterisa-
tion in the context of both epidemiological and
possibly clinic-based and treatment studies. Our
work suggests that they may not be most appropri-
ately considered as having a neurodevelopmental
disorder and a crucial issue is whether treatments
currently recommended for ADHD are effective in
this group. Due to the transitional age of the
individuals involved, this has implications for
practice in both child and adolescent mental health
services and adult psychiatric services.
Supporting information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Comparisons of the ADHD symptom groups
on emotional, behavioural and social problems using
complete cases.
Table S2. Comparisons of the ADHD symptom groups
on neurodevelopmental characteristics and educational
attainment using complete cases.
Table S3. Association with sample retention.
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Key points
• ADHD is currently conceptualised as a childhood-onset neurodevelopmental disorder.
• Recent research has challenged this assumption, with several longitudinal studies finding evidence for a group
of individuals with ADHD symptoms arising for the first time after childhood.
• Using the ALSPAC dataset, we have identified a small group of individuals with ADHD symptoms arising in late
adolescence who do not have a profile of neurodevelopmental impairments typical of ADHD.
• Our work suggests that this group may not be most appropriately considered as having a neurodevelopmental
disorder, and a crucial issue for further exploration is whether treatments currently recommended for ADHD
are effective in this group.
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